Finally, we assessed aortic valve osteocalcin expression as a down-stream mediator of BMP2 signaling and marker of valvular calcification in CAVD.6 This evidence concerns the gene BMP2 and congenital bilateral aplasia of vas deferens from CFTR mutation.